+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Intraocular Lens Market - Global Outlook & Forecast 2023-2028

  • PDF Icon


  • 281 Pages
  • March 2023
  • Region: Global
  • Arizton
  • ID: 5743995
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global intraocular lens market is expected to grow at a CAGR of 7.25% from 2022 to 2028


Adoption & Penetration of Premium IOLs

In 2021, approximately 29.7 million cataract surgeries were performed worldwide, including 4.7 million in the US alone. Cataracts increase in prevalence with age, affecting about 50% of people by age 60, affecting both eyes 80% to 90% of the time, and requiring surgery to restore vision. In addition, the premium intraocular lens (IOL) market is projected to grow significantly faster as worldwide cataract procedure volumes return to pre-COVID-19 levels. Global premium IOLs revenues are expected to grow at a CAGR of 9.03% from USD 1.5 billion in 2021 to USD 2.5 billion in 2028, compared to a 6.2% CAGR revenue growth for the traditional IOL.

Product Innovation and Next-Generation IOL

Vendors in the intraocular lens market are focused on using innovative technology platforms to increase the comfort and ease of use for IOLs. Technological enhancements to existing product lines and innovations in new products have markedly improved the product entrenchment of IOLs in the recent past. Intraocular lens (IOLs) has undergone tremendous advances, especially over the last 5-10 years. Modern-day cataract surgery mostly consists of phacoemulsification for cataract removal and implantation of an IOL. Advances in lens technology have included toric lenses for astigmatism correction and multifocal, trifocal, and extended-depth-of-focus lenses for presbyopia correction.

Rapidly Evolving Cataract Surgical Technology

The prevalence of cataracts aged 40 years and older is approximately 11.8% to 18.8%. Currently, cataract surgery is a widely adopted way to treat cataracts. Cataract surgery has evolved from vision restoration to refractive surgery. It led to the era of refractive cataract surgery, where premium intraocular lenses (IOLs) such as toric IOLs, multifocal IOLs, and extended-depth-of-focus IOLs are increasingly being used to meet the needs of patients. In addition to intraocular lens calculation and design, improving operation technology may also play a decisive role in further improving the visual effect after the operation.

Rising Prevalence of Vision Impairments

Globally, more than 80% of impaired vision cases are preventable with early diagnosis and treatment. As the world population ages, the need for quality vision care is expanding and evolving with the availability of a diverse range of IOLs for several vision impairments. By 2030, the number of people worldwide aged 60 years and over is estimated to increase from 962 million (2017) to 1.4 billion, while those over 80 years will increase from 137 million (2017) to 202 million. It has been projected to increase 1.3 times between 2020 (76 million) and 2030 (95.4 million), and those with age-related macular degeneration, 1.2 times between 2020 (195.6 million) and 2030 (243.3 million).

Advances in IOL Materials and Surface Modification in Cataract Surgery

Advances in IOL include materials and structural design. In the optical structure design, multiple foci were achieved by refraction, diffraction, or combining two surface structures, resulting in sharp images at multiple distances. Extended depth-of-focus (EDOF) IOLs, Toric IOLs, and Aspheric IOLs are designed to improve the quality of vision. Regarding the non-optical part, square-edge IOLs effectively inhibit cell proliferation and reduce postoperative side effects. There are many advances in IOL materials today. The intraocular lens (IOL) market has evolved from rigid materials to foldable and soft materials, and currently, commercially available IOLs are mainly made of various acrylics. Materials have been improved to reduce the size of the IOL, prevent side effects after IOL implantation and surgery, improve biocompatibility, provide adaptability, and filter specific light. In the future, it is hoped that IOLs will more closely resemble the original lens.



The global intraocular lens market is segmented into polycarbonate, plastic, and others by product type. Among the product segment, the traditional/monofocal IOL segment dominates the industry with a share of 61.37% and will likely witness the highest incremental growth over the forecast period. Monofocal IOLs have been around the longest and are still the most commonly used IOLs today. The quality of materials and designs continues to improve, but the functionality of the lenses remains the same. A monofocal IOL has equal power in all areas, has a single zone of clear focus, and provides excellent visual acuity at a given distance. Monofocal intraocular lenses may be made of polymethyl methacrylate (PMMA), which is rigid. Foldable IOL materials include silicone, hydrophobic, and hydrophilic acrylic materials.

Segmentation by Product

  • Traditional/Monofocal IOL
  • Premium IOL
  • Phakic IOL


The hydrophobic acrylic material segment dominates the global intraocular lens market with a share of 54.80%. It will likely witness the highest incremental growth of USD 1.4 billion over the forecast period. Hydrophobic acrylic IOLs are modern foldable IOLs most widely used nowadays. They are designed as copolymers of acrylate and methacrylate derived from PMMA. The new design intends to make the IOL foldable. They can be manipulated during the surgery and always return to their original shape quickly. Single-piece and multi-piece hydrophobic IOLs can be implanted through small incisions of 2.2 mm or larger but must be positioned appropriately because of their poor self-centering ability. For hydrophobic acrylic lenses, PCO is significantly lower than PMMA IOLs, but generally slightly higher than silicone. The hydrophilic acrylic segment is likely to witness the highest CAGR of 7.59%, with incremental growth of USD 789.03 million, and is expected to fuel the intraocular lens (IOL) market over the forecast period.

Segmentation by Material

  • Hydrophobic Acrylic
  • Hydrophilic Acrylic
  • Silicone
  • PMMA


The global intraocular lens market by end-user segments into standalone eye care centers & ASCs, hospitals, and eye research institutes. The standalone eye care centers & ASCs segment accounted for a major share of 63.62% in 2022 and is anticipated to retain its industry dominance during the forecast period. This end-user segment is vital, especially for IOL implantation and cataract surgery. Eye care centers are healthcare facilities that exclusively focus on treating vision ailments. These facilities cover individuals' primary eye care needs in contrast to hospitals, which cater to numerous specialized treatments. People most commonly prefer these facilities for primary follow-ups and treatment for eye health. The standalone eye care centers & ASCs segment is projected to register a CAGR of 7.67% during the forecast period 2022-2028.

Segmentation by End-user

  • Standalone Eye Care Centers & ASCs
  • Hospitals
  • Eye Research Institutes


North America accounted for the largest share of 35.57% in the global intraocular lens market in 2022. The region has a developed infrastructure for healthcare services, a high amount of adoption of advanced products in eye care services, and high expenditure driving higher market growth. The increasing awareness and rising geriatric population are expected to drive market growth in the upcoming years. The increasing aging population will drive the demand for eye diagnosis. The increasing demand for cataract and glaucoma diagnosis will also influence the market growth. The region's demand for vision care products is driven by high awareness, better product availability, and an extensive reach of innovative products. The same is also reinforced by a well-connected and sophisticated healthcare delivery and distribution network. Further, the region has high accessibility to vision care products and services.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey


The global intraocular lens market is concentrated in nature, with a limited number of major players accounting for commendable market shares. Alcon, Bausch & Lomb, HOYA, Johnson & Johnson, and ZEISS dominate the market. Oculentis, Ophtec, PhysIOL, Rayner Group, and STAAR Surgical Company are vendors offering a broad range of IOLs and accounting for reasonable shares in the global intraocular lens market. Many key players are adopting several organic and inorganic growth strategies, such as new product launches, distribution agreements, partnerships, M&As, and geographic expansions, to expand their customer base and increase shares in the market.

Key Company Profiles

  • Alcon
  • Bausch & Lomb
  • HOYA
  • Johnson & Johnson

Other Prominent Vendors

  • AcuFocus
  • Aurolab
  • Biotech Healthcare Group
  • BVI
  • Care Group
  • Excellent Hi-Care
  • Eyekon Medical
  • Hanita Lenses
  • HumanOptics
  • Lenstec
  • Omni Lens
  • Ophtec
  • Rayner Group
  • SIFI S.p.A


1. How big is the global intraocular lens market?
2. What is the growth rate of the intraocular lens market?
3. What are the growing trends in the intraocular lens market?
4. Who are the key players in the global intraocular lens market?
5. Which region holds the most significant global intraocular lens market share?

Table of Contents

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Product
4.3.2 Market Segmentation by Material
4.3.3 Market Segmentation by End-User
4.3.4 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Premium Insights
6.1 Overview

7 Market at a Glance

8 Introduction
8.1 Overview

9 Market Opportunities & Trends
9.1 Adoption & Penetration of Premium Iols
9.2 Product Innovation & Next-Generation Iols
9.3 Advances in Cataract Surgical Technology

10 Market Growth Enablers
10.1 Prevalence of Vision Impairment
10.2 R&D & Product Launches
10.3 Iol Material Advances & Iol Surface Modifications

11 Market Restraints
11.1 Complications Associated With Cataract Surgery
11.2 Lack of Reimbursement for Premium Iols
11.3 Limitations of Premium Iols & Scarcity of Ophthalmologists

12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Geography Insights
12.2.2 Product Insights
12.2.3 Material Insights
12.2.4 End-User Insights
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry

13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Traditional/Monofocal Iol
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Traditional/Monofocal Iol Segment by Geography
13.4 Premium Iol
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Premium Iol Segment by Geography
13.5 Phakic Iol
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Phakic Iol Segment by Geography

14 Material
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hydrophobic Acrylic
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Hydrophobic Acrylic Segment by Geography
14.4 Hydrophilic Acrylic
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Hydrophilic Acrylic Segment by Geography
14.5 Silicone
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Silicone Segment by Geography
14.6 Pmma
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Pmma Segment by Geography

15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Standalone Eye Care Centers & Ascs
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Standalone Eye Care Centers & Ascs Segment by Geography
15.4 Hospitals
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Hospitals Segment by Geography
15.5 Eye Research Institutes
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Eye Research Institutes Segment by Geography

16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview

17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.2.1 North America by Product Segmentation
17.2.2 North America by Material Segmentation
17.2.3 North America by End-User Segmentation
17.3 Key Countries
17.3.1 Us: Market Size & Forecast
17.3.2 Canada: Market Size & Forecast

18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.2.1 Europe by Product Segmentation
18.2.2 Europe by Material Segmentation
18.2.3 Europe by End-User Segmentation
18.3 Key Countries
18.3.1 Germany: Market Size & Forecast
18.3.2 France: Market Size & Forecast
18.3.3 Uk: Market Size & Forecast
18.3.4 Spain: Market Size & Forecast
18.3.5 Italy: Market Size & Forecast

19 Apac
19.1 Market Overview
19.2 Market Size & Forecast
19.2.1 APAC by Product Segmentation
19.2.2 APAC by Material Segmentation
19.2.3 APAC by End-User Segmentation
19.3 Key Countries
19.3.1 China: Market Size & Forecast
19.3.2 Japan: Market Size & Forecast
19.3.3 India: Market Size & Forecast
19.3.4 South Korea: Market Size & Forecast
19.3.5 Australia: Market Size & Forecast

20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.2.1 Latin America by Product Segmentation
20.2.2 Latin America by Material Segmentation
20.2.3 Latin America by End-User Segmentation
20.3 Key Countries
20.3.1 Brazil: Market Size & Forecast
20.3.2 Mexico: Market Size & Forecast
20.3.3 Argentina: Market Size & Forecast

21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.2.1 Middle East & Africa by Product Segmentation
21.2.2 Middle East & Africa by Material Segmentation
21.2.3 Middle East & Africa by End-User Segmentation
21.3 Key Countries
21.3.1 Turkey: Market Size & Forecast
21.3.2 South Africa: Market Size & Forecast
21.3.3 Saudi Arabia: Market Size & Forecast

22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Alcon
22.2.2 Bausch & Lomb
22.2.3 Hoya
22.2.4 Johnson & Johnson
22.2.5 Zeiss

23 Key Company Profiles
23.1 Alcon
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Bausch & Lomb
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Hoya
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 Johnson & Johnson
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Zeiss
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities

24 Other Prominent Vendors
24.1 Acufocus
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 Aurolab
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 Biotech
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Bvi
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Care Group
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 Excellent Hi-Care
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Eyekon Medical
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Hanita Lenses
24.8.1 Business Overview
24.8.2 Product Offerings
24.9 Humanoptics
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Lenstec
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Nidek
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 Omni Lens
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 Ophtec
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Rayner Group
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Rxsight
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Sav-Iol
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 Sifi Spa
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 Staar Surgical
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 Teleon
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Zaraccom Lenses
24.20.1 Business Overview
24.20.2 Product Offerings

25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations

26 Quantitative Summary
26.1 Market by Product
26.1.1 North America by Product Segmentation
26.1.2 Europe by Product Segmentation
26.1.3 APAC by Product Segmentation
26.1.4 Latin America by Product Segmentation
26.1.5 Middle East & Africa by Product Segmentation
26.2 Market by Material
26.2.1 North America by Material Segmentation
26.2.2 Europe by Material Segmentation
26.2.3 APAC by Material Segmentation
26.2.4 Latin America by Material Segmentation
26.2.5 Middle East & Africa by Material Segmentation
26.3 Market by End-User
26.3.1 North America by End-User Segmentation
26.3.2 Europe by End-User Segmentation
26.3.3 APAC by End-User Segmentation
26.3.4 Latin America by End-User Segmentation
26.3.5 Middle East & Africa by End-User Segmentation
26.4 Market by Geography
26.4.1 Traditional/Monofocal Iol Segment by Geography
26.4.2 Premium Iol Segment by Geography
26.4.3 Phakic Iol Segment by Geography
26.4.4 Hydrophobic Acrylic Segment by Geography
26.4.5 Hydrophilic Acrylic Segment by Geography
26.4.6 Silicone Segment by Geography
26.4.7 Pmma Segment by Geography
26.4.8 Standalone Eye Care Centers & Ascs Segment by Geography
26.4.9 Hospitals Segment by Geography
26.4.10 Eye Research Institutes Segment by Geography

27 Appendix
27.1 Abbreviations

Companies Mentioned

  • Alcon
  • Bausch & Lomb
  • HOYA
  • Johnson & Johnson
  • AcuFocus
  • Aurolab
  • Biotech Healthcare Group
  • BVI
  • Care Group
  • Excellent Hi-Care
  • Eyekon Medical
  • Hanita Lenses
  • HumanOptics
  • Lenstec
  • Omni Lens
  • Ophtec
  • Rayner Group
  • SIFI S.p.A


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



Table Information